J Vantelon

598 total citations
24 papers, 296 citations indexed

About

J Vantelon is a scholar working on Nephrology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, J Vantelon has authored 24 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in J Vantelon's work include Lymphoma Diagnosis and Treatment (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Dialysis and Renal Disease Management (3 papers). J Vantelon is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Dialysis and Renal Disease Management (3 papers). J Vantelon collaborates with scholars based in France and Belgium. J Vantelon's co-authors include Philippe Bierling, Serge Koscielny, Bertrand Godeau, Jean Bourhis, Ahmad Aljijakli, Dany Gholam, Vincent Ribrag, A Lavergne, Christian Verger and Patrice Carde and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

J Vantelon

23 papers receiving 282 citations

Peers

J Vantelon

PFM

ONCOL

NEPHR

HEMAT

SURGE

T. E. Blecher United Kingdom

Francisco Javier Jiménez-Balderas Mexico

Jorge Labrador Spain

R. Meadows Australia

Leonardo Caroti Italy

Giancarlo Basile Italy

S.C. Mayou United Kingdom

Adolfo Camargo‐Coronel Mexico

Y. Tanter France

Samhar Al‐Akash United States

T. E. Blecher United Kingdom

J Vantelon

59 ×0.6

PFM

30 ×0.3

ONCOL

15 ×0.2

NEPHR

59 ×0.9

HEMAT

54 ×1.3

SURGE

Citations per year, relative to J Vantelon J Vantelon (= 1×) peers T. E. Blecher

Countries citing papers authored by J Vantelon

Since Specialization

Citations

This map shows the geographic impact of J Vantelon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Vantelon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Vantelon more than expected).

Fields of papers citing papers by J Vantelon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Vantelon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Vantelon. The network helps show where J Vantelon may publish in the future.

Co-authorship network of co-authors of J Vantelon

This figure shows the co-authorship network connecting the top 25 collaborators of J Vantelon. A scholar is included among the top collaborators of J Vantelon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Vantelon. J Vantelon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jabbour, Elias, Serge Koscielny, Catherine Sebban, et al.. (2006). High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). Leukemia. 20(5). 814–819. 25 indexed citations

Ribrag, Vincent, Florence Suzan, Christophe Ravoet, et al.. (2003). Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts. Leukemia. 17(2). 319–322. 5 indexed citations

Gholam, Dany, J Vantelon, Ahmad Aljijakli, & Jean Bourhis. (2003). A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Annals of Hematology. 82(12). 766–768. 31 indexed citations

Résière, Dabor, J Vantelon, Patrice Bourée, et al.. (2003). Isospora belli infection in a patient with non-Hodgkin's lymphoma. Clinical Microbiology and Infection. 9(10). 1065–1067. 19 indexed citations

Ribrag, Vincent, Serge Koscielny, J Vantelon, et al.. (2003). Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgki n's Lymphomas. Leukemia & lymphoma. 44(9). 1529–1533. 11 indexed citations

Carpiuc, Ioana, S. Antoun, J Vantelon, et al.. (2002). Segmental Coecal Cytomegalovirus Colitis During Fludarabine, Cytarabine and Mitoxantrone Induction Chemotherapy for Myelodysplastic Syndrome. Leukemia & lymphoma. 43(8). 1701–1703. 4 indexed citations

Kérob, Delphine, J Vantelon, Vincent Ribrag, et al.. (2002). [Cutaneous localization of multiple myeloma on the tract of a central venous catheter].. PubMed. 129(3). 311–4. 4 indexed citations

Girinsky, T., Serge Koscielny, G. Ganem, et al.. (2001). A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. International Journal of Radiation Oncology*Biology*Physics. 51(1). 148–155. 52 indexed citations

Ruivard, M., Mathieu Caulier, J Vantelon, et al.. (1999). The response to high‐dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. British Journal of Haematology. 105(4). 1130–1132. 34 indexed citations

10.

Ulusakarya, Ayhan, J. Lumbroso, Odile Casiraghi, et al.. (1999). Gallium Scan in the Evaluation of Post Chemotherapy Mediastinal Residual Masses of Aggressive Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 35(5-6). 579–586. 8 indexed citations

11.

Droz, D, et al.. (1983). [Autoimmune thyroid diseases associated with glomerular nephropathy. 3 cases].. PubMed. 12(2). 83–6. 4 indexed citations

12.

Verger, Christian, et al.. (1981). Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.. PubMed. 18. 199–205. 37 indexed citations

13.

Vantelon, J, et al.. (1977). [Is it possible to treat uremia by hemofiltration? Initial clinical results obtained with a poly-acrylo-nytril membrane].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(13). 1117–20. 1 indexed citations

14.

Funck‐Brentano, J.L., P Chaumont, J Vantelon, & J. Zingraff. (1968). Polynévrite au cours de l’urémie chronique. The Nephron journals/Nephron journals. 5(1). 31–42. 9 indexed citations

15.

Vantelon, J, et al.. (1968). [Development of hypertension and plasma renin activity in 7 anephric patients].. PubMed. 74(12). 950–6. 1 indexed citations

16.

Chaumont, P, et al.. (1966). Signes électriques et électromyographiques des urémies chroniques graves après transplantation rénale.. Revue Neurologique. 115(1). 2 indexed citations

17.

Chaumont, P, et al.. (1966). [Electrical and electromyographical signs of grave chronic uremia after renal transplantation].. PubMed. 115(1). 150–3. 2 indexed citations

18.

Vantelon, J, et al.. (1964). [THE EVENTUAL COMPLICATIONS OF RENAL POLYCYSTIC DISEASE. 154 PERSONAL CASES].. PubMed. 72. 1583–8. 5 indexed citations

19.

Vantelon, J, et al.. (1964). [Treatment of chronic uremia with the artificial kidney].. PubMed. 40(2). 88–90. 1 indexed citations

20.

Vantelon, J, et al.. (1963). [The acute renal insufficiencies of "uremigenic angiocholitis" (18 personel cases)].. PubMed. 71. 1039–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact